Do mast cells link obesity and asthma?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 1, 2013, Pages 8-15

  Sismanopoulos, N ^a,d   Delivanis, D A ^a,e   Mavrommati, D ^a   Hatziagelaki, E ^b   Conti, P ^c   Theoharides, T C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

adipocytokines; asthma; cytokines; inflammation; obesity; treatment

Indexed keywords

ADIPOCYTOKINE; BRONCHODILATING AGENT; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CROMOGLYCATE DISODIUM; FLAVONOID; GLUCOCORTICOID; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 33; INTERLEUKIN 9; KETOTIFEN; NEUROTENSIN; OMALIZUMAB; SUBSTANCE P; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ASTHMA; AUTOCRINE EFFECT; CELL INFILTRATION; DISEASE ASSOCIATION; DISEASE SEVERITY; GLUCOSE INTOLERANCE; HUMAN; INFECTION; INFLAMMATION; MAST CELL; NONHUMAN; OBESITY; PNEUMONIA; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTHMA; HUMANS; INFLAMMATION; MAST CELLS; OBESITY; PNEUMONIA; STRESS, PHYSIOLOGICAL;

EID: 84870616314     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12043     Document Type: Review

References (123)

1. Jackson DJ, Sykes A, Mallia P, Johnston SL,. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128: 1165-1174.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
3. Beuther DA, Sutherland ER,. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175: 661-666.
4. Mukherjee AB, Zhang Z,. Allergic asthma: influence of genetic and environmental factors. J Biol Chem 2011; 286: 32883-32889.
5. Chanez P, Wenzel SE, Anderson GP, Anto JM, Bel EH, Boulet LP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007; 119: 1337-1348.
6. Gregor MF, Hotamisligil GS,. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
7. Hotamisligil GS,. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
8. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360: 1509-1517.
9. Ahima RS, Flier JS,. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
10. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
11. Theoharides TC, Makris M, Kalogeromitros D,. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21: 1-4.
12. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009; 29: 359-370.
13. Schroder K, Zhou R, Tschopp J,. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010; 327: 296-300.
14. Shoelson SE, Lee J, Goldfine AB,. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
15. Saint-Pierre P, Bourdin A, Chanez P, Daures JP, Godard P,. Are overweight asthmatics more difficult to control? Allergy 2006; 61: 79-84.
16. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B,. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006; 100: 648-657.
17. Tantisira KG, Litonjua AA, Weiss ST, Fuhlbrigge AL,. Association of body mass with pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax 2003; 58: 1036-1041.
18. Varraso R, Siroux V, Maccario J, Pin I, Kauffmann F,. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med 2005; 171: 334-339.
19. Ma J, Xiao L, Knowles SB,. Obesity, insulin resistance and the prevalence of atopy and asthma in US adults. Allergy 2010; 65: 1455-1463.
20. Bradding P, Walls AF, Holgate ST,. The role of the mast cells in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117: 1277-1284.
21. Moiseeva EP, Bradding P,. Mast cells in lung inflammation. Adv Exp Med Biol 2011; 716: 235-269.
22. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
23. Theoharides TC, Sismanopoulos N, Delivanis DA, Zhang B, Hatziagelaki EE, Kalogeromitros D,. Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity. Trends Pharmacol Sci 2011; 32: 534-542.
24. Zhang J, Shi GP,. Mast cells and metabolic syndrome. Biochim Biophys Acta 2012; 1822: 14-20.
25. Sick E, Brehin S, Andre P, Coupin G, Landry Y, Takeda K, et al. Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol 2010; 161: 442-455.
26. Tilg H, Moschen AR,. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
27. Lago R, Gomez R, Lago F, Gomez-Reino J, Gualillo O,. Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol 2008; 252: 139-145.
28. Mai XM, Bottcher MF, Leijon I,. Leptin and asthma in overweight children at 12 years of age. Pediatr Allergy Immunol 2004; 15: 523-530.
29. Baek HS, Kim YD, Shin JH, Kim JH, Oh JW, Lee HB,. Serum leptin and adiponectin levels correlate with exercise-induced bronchoconstriction in children with asthma. Ann Allergy Asthma Immunol 2011; 107: 14-21.
30. Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F,. Leptin: does it have any role in childhood asthma? J Allergy Clin Immunol 2004; 114: 254-259.
31. Shore SA, Schwartzman IN, Mellema MS, Flynt L, Imrich A, Johnston RA,. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol 2005; 115: 103-109.
32. Jartti T, Saarikoski L, Jartti L, Lisinen I, Jula A, Huupponen R, et al. Obesity, adipokines and asthma. Allergy 2009; 64: 770-777.
33. Taildeman J, Perez-Novo CA, Rottiers I, Ferdinande L, Waeytens A, De C V, et al. Human mast cells express leptin and leptin receptors. Histochem Cell Biol 2009; 131: 703-711.
34. Meier U, Gressner AM,. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
35. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ,. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011; 27: 515-527.
36. Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, et al. Visfatin: the link between inflammation and childhood obesity. Diabetes Care 2009; 32: e71.
37. Nagaev I, Bokarewa M, Tarkowski A, Smith U,. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006; 1: e31.
38. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ,. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101.
39. Larochelle J, Freiler J, Dice J, Hagan L,. Plasma resistin levels in asthmatics as a marker of disease state. J Asthma 2007; 44: 509-513.
40. Matter CM, Handschin C,. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation 2007; 115: 946-948.
41. Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 1997; 89: 4120-4127.
42. Lugogo NL, Bappanad D, Kraft M,. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta 2011; 1810: 1120-1126.
43. Shore SA, Fredberg JJ,. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol 2005; 115: 925-927.
44. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P,. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320: 827-832.
45. Holguin F, Rojas M, Brown LA, Fitzpatrick AM,. Airway and plasma leptin and adiponectin in lean and obese asthmatics and controls. J Asthma 2011; 48: 217-223.
46. Nagel G, Koenig W, Rapp K, Wabitsch M, Zoellner I, Weiland SK,. Associations of adipokines with asthma, rhinoconjunctivitis, and eczema in German schoolchildren. Pediatr Allergy Immunol 2009; 20: 81-88.
47. Rothenbacher D, Weyermann M, Fantuzzi G, Brenner H,. Adipokines in cord blood and risk of wheezing disorders within the first two years of life. Clin Exp Allergy 2007; 37: 1143-1149.
48. Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC,. The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 2011; 128: 964-969.
49. Suglia SF, Chambers EC, Rosario A, Duarte CS,. Asthma and obesity in three-year-old urban children: role of sex and home environment. J Pediatr 2011; 159: 14-20.
50. Sood A, Dominic E, Qualls C, Steffes MW, Thyagarajan B, Smith LJ, et al. Serum adiponectin is associated with adverse outcomes of asthma in men but not in women. Front Pharmacol 2011; 2: 55.
51. Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, et al. Low serum adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med 2012; 186: 41-47.
52. Sutherland TJ, Cowan JO, Young S, Goulding A, Grant AM, Williamson A, et al. The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med 2008; 178: 469-475.
53. Carroll CL, Stoltz P, Raykov N, Smith SR, Zucker AR,. Childhood overweight increases hospital admission rates for asthma. Pediatrics 2007; 120: 734-740.
54. Carroll CL, Bhandari A, Zucker AR, Schramm CM,. Childhood obesity increases duration of therapy during severe asthma exacerbations. Pediatr Crit Care Med 2006; 7: 527-531.
55. Fitzpatrick S, Joks R, Silverberg JI,. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy 2012; 42: 747-759.
56. Wood LG, Gibson PG,. Dietary factors lead to innate immune activation in asthma. Pharmacol Ther 2009; 123: 37-53.
57. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007; 42: 665-674.
58. Komakula S, Khatri S, Mermis J, Savill S, Haque S, Rojas M, et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 2007; 8: 32.
59. Kelley J, Hemontolor G, Younis W, Li C, Krishnaswamy G, Chi DS,. Mast cell activation by lipoproteins. Methods Mol Biol 2006; 315: 341-348.
60. Theoharides TC, Kalogeromitros D,. The critical role of mast cell in allergy and inflammation. Ann N Y Acad Sci 2006; 1088: 78-99.
61. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta 2010; 1822: 21-33.
62. Boyce JA,. The role of mast cells in asthma. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 195-205.
63. Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD,. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004; 114: 174-182.
64. McCurdy JD, Olynych TJ, Maher LH, Marshall JS,. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003; 170: 1625-1629.
65. Kraneveld AD, Kool M, van Houwelingen AH, Roholl P, Solomon A, Postma DS, et al. Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci U S A 2005; 102: 1578-1583.
66. Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, Gabay C,. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007; 40: 216-225.
67. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007; 87: 971-978.
68. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C,. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011; 186: 2523-2528.
69. Hsu CL, Neilsen CV, Bryce PJ,. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 2010; 5: e11944.
70. Eiwegger T, Akdis CA,. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol 2011; 41: 1535-1538.
71. Hauber HP, Bergeron C, Hamid Q,. IL-9 in allergic inflammation. Int Arch Allergy Immunol 2004; 134: 79-87.
72. Kearley J, Erjefalt JS, Andersson C, Benjamin E, Jones CP, Robichaud A, et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 2011; 183: 865-875.
73. Donelan J, Boucher W, Papadopoulou N, Lytinas M, Papaliodis D, Theoharides TC,. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A 2006; 103: 7759-7764.
74. Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 2010; 107: 4448-4453.
75. Balzar S, Fajt ML, Comhair SA, Erzurum SC, Bleecker E, Busse WW, et al. Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program. Am J Respir Crit Care Med 2011; 183: 299-309.
76. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID,. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
77. Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R, Berger P,. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Ther 2011; 130: 325-337.
78. Bingham CO III, Austen KF,. Mast-cell responses in the development of asthma. J Allergy Clin Immunol 2000; 105: S527-S534.
79. Cruse G, Kaur D, Yang W, Duffy SM, Brightling CE, Bradding P,. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005; 25: 858-863.
80. Bradding P,. The role of the mast cell in asthma: a reassessment. Curr Opin Allergy Clin Immunol 2003; 3: 45-50.
81. Kunder CA, St John AL, Li G, Leong KW, Berwin B, Staats HF, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009; 206: 2455-2467.
82. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
83. Kempuraj D, Tagen M, Iliopoulou BP, Clemons A, Vasiadi M, Boucher W, et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol 2008; 155: 1076-1084.
84. Thomas PS, Heywood G,. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 2002; 57: 774-778.
85. Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009; 114: 2639-2648.
86. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490-500.
87. Hollins F, Kaur D, Yang W, Cruse G, Saunders R, Sutcliffe A, et al. Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J Immunol 2008; 181: 2772-2780.
88. Woodman L, Siddiqui S, Cruse G, Sutcliffe A, Saunders R, Kaur D, et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol 2008; 181: 5001-5007.
89. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D,. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007; 217: 65-78.
90. Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 2003; 171: 4830-4836.
91. Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005; 174: 7665-7675.
92. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 2003; 33: 899-906.
93. Nigo YI, Yamashita M, Hirahara K, Shinnakasu R, Inami M, Kimura M, et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci U S A 2006; 103: 2286-2291.
94. Chen K, Xiang Y, Yao X, Liu Y, Gong W, Yoshimura T, et al. The active contribution of Toll-like receptors to allergic airway inflammation. Int Immunopharmacol 2011; 11: 1391-1398.
95. Alkhouri H, Hollins F, Moir LM, Brightling CE, Armour CL, Hughes JM,. Human lung mast cells modulate the functions of airway smooth muscle cells in asthma. Allergy 2011; 66: 1231-1241.
96. Andersson CK, Tufvesson E, Aronsson D, Bergqvist A, Mori M, Bjermer L, et al. Alveolar mast cells shift to an FcepsilonRI-expressing phenotype in mild atopic asthma: a novel feature in allergic asthma pathology. Allergy 2011; 66: 1590-1597.
97. Theoharides TC, Cochrane DE,. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004; 146: 1-12.
98. Wright RJ, Cohen RT, Cohen S,. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005; 5: 23-29.
99. Chida Y, Hamer M, Steptoe A,. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008; 70: 102-116.
100. Chen E, Miller GE,. Stress and inflammation in exacerbations of asthma. Brain Behav Immun 2007; 21: 993-999.
101. Theoharides TC, Enakuua S, Sismanopoulos N, Papadimas E, Angelidou A, Alysandratos K,. Stress contributes to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol 2012; 109: 14-19.
102. Girodet PO, Ozier A, Trian T, Begueret H, Ousova O, Vernejoux JM, et al. Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6. Allergy 2010; 65: 1004-1012.
103. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998; 139: 403-413.
104. Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IM,. Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab 2003; 88: 5427-5432.
105. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, et al. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 2004; 145: 43-48.
106. Oh SH, Park CO, Wu WH, Kim JY, Jin S, Byamba D, et al. Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2012; 129: 151-159.
107. Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, et al. Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 2004; 89: 965-970.
108. Peters JL, Cohen S, Staudenmayer J, Hosen J, Platts-Mills TA, Wright RJ,. Prenatal negative life events increases cord blood IgE: interactions with dust mite allergen and maternal atopy. Allergy 2012; 67: 545-551.
109. Boulet LP, Franssen E,. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101: 2240-2247.
110. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM,. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006; 27: 495-503.
111. Vieira Dos SR, Magerl M, Martus P, Zuberbier T, Church MK, Escribano L, et al. Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol 2010; 162: 674-676.
112. Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS ONE 2012; 7: e33805
113. James A, Gyllfors P, Henriksson E, Dahlen SE, Adner M, Nilsson G, et al. Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi. Allergy 2012; 67: 958-961.
114. Bousquet J, Siergiejko Z, Swiebocka E, Humbert M, Rabe KF, Smith N, et al. Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma. Allergy 2011; 66: 671-678.
115. Rabe KF, Calhoun WJ, Smith N, Jimenez P,. Can anti-IgE therapy prevent airway remodeling in allergic asthma? Allergy 2011; 66: 1142-1151.
116. Eggel A, Buschor P, Baumann MJ, Amstutz P, Stadler BM, Vogel M,. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein. Allergy 2011; 66: 961-968.
117. Middleton E Jr, Kandaswami C, Theoharides TC,. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000; 52: 673-751.
118. Kimata M, Schchijo M, Miura T, Serizawa I, Inagaki N, Nagai H,. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 1999; 30: 501-508.
119. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 2005; 145: 934-944.
120. Rogerio AP, Kanashiro A, Fontanari C, da Silva EV, Lucisano-Valim YM, Soares EG, et al. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 2007; 56: 402-408.
121. Wootten D, Simms J, Koole C, Woodman OL, Summers RJ, Christopoulos A, et al. Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids. J Pharmacol Exp Ther 2011; 336: 540-550.
122. Ando C, Takahashi N, Hirai S, Nishimura K, Lin S, Uemura T, et al. Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation. FEBS Lett 2009; 583: 3649-3654.
123. Deqiu Z, Kang L, Jiali Y, Baolin L, Gaolin L,. Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium. Biochimie 2011; 93: 506-512.